Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 34717-03-8
2. Orotate Magnesium
3. Magnesium;2,4-dioxo-1h-pyrimidine-6-carboxylate
4. Orotic Acid, Magnesium Salt
5. Gi96w46m5a
6. Magnesium Bis(2,6-dioxo-1,2,3,6-tetrahydro-4-pyrimidinecarboxylate)
7. Bis(1,2,3,6-tetrahydro-2,6-dioxopyrimidine-4-carboxylato-n3,o4)magnesium
8. 27067-77-2
9. Unii-gi96w46m5a
10. Einecs 252-167-6
11. Schembl159382
12. Chembl3707282
13. Dtxsid20905129
14. Magnesium Orotate [who-dd]
15. Akos005267180
16. Ac-7503
17. Db13786
18. Magnesium, Bis(1,2,3,6-tetrahydro-2,6-dioxo-4-pyrimidinecarboxylato-.kappa.n3,.kappa.o4)-, (t-4)-
19. Ft-0682956
20. A822363
21. Q9053193
22. Magnesium 2,6-dioxo-3h-pyrimidine-4-carboxylate
23. 1h-azepine,1-[2-[1-(4-chlorophenyl)-1-phenylethoxy]ethyl]hexahydro-
24. Magnesium, Bis(1,2,3,6-tetrahydro-2,6-dioxo-4-pyrimidinecarboxylato-kappan3,kappao4)-, (t-4)-
Molecular Weight | 334.48 g/mol |
---|---|
Molecular Formula | C10H6MgN4O8 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 0 |
Exact Mass | 334.0036049 g/mol |
Monoisotopic Mass | 334.0036049 g/mol |
Topological Polar Surface Area | 197 Ų |
Heavy Atom Count | 23 |
Formal Charge | 0 |
Complexity | 262 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
A - Alimentary tract and metabolism
A12 - Mineral supplements
A12C - Other mineral supplements
A12CC - Magnesium
A12CC09 - Magnesium orotate
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Market Place
ABOUT THIS PAGE
A Magnesium Orotate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Magnesium Orotate, including repackagers and relabelers. The FDA regulates Magnesium Orotate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Magnesium Orotate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Magnesium Orotate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Magnesium Orotate supplier is an individual or a company that provides Magnesium Orotate active pharmaceutical ingredient (API) or Magnesium Orotate finished formulations upon request. The Magnesium Orotate suppliers may include Magnesium Orotate API manufacturers, exporters, distributors and traders.
click here to find a list of Magnesium Orotate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Magnesium Orotate written confirmation (Magnesium Orotate WC) is an official document issued by a regulatory agency to a Magnesium Orotate manufacturer, verifying that the manufacturing facility of a Magnesium Orotate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Magnesium Orotate APIs or Magnesium Orotate finished pharmaceutical products to another nation, regulatory agencies frequently require a Magnesium Orotate WC (written confirmation) as part of the regulatory process.
click here to find a list of Magnesium Orotate suppliers with Written Confirmation (WC) on PharmaCompass.
Magnesium Orotate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Magnesium Orotate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Magnesium Orotate GMP manufacturer or Magnesium Orotate GMP API supplier for your needs.
A Magnesium Orotate CoA (Certificate of Analysis) is a formal document that attests to Magnesium Orotate's compliance with Magnesium Orotate specifications and serves as a tool for batch-level quality control.
Magnesium Orotate CoA mostly includes findings from lab analyses of a specific batch. For each Magnesium Orotate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Magnesium Orotate may be tested according to a variety of international standards, such as European Pharmacopoeia (Magnesium Orotate EP), Magnesium Orotate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Magnesium Orotate USP).
LOOKING FOR A SUPPLIER?